These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32834115)

  • 1. Chemical-informatics approach to COVID-19 drug discovery: Exploration of important fragments and data mining based prediction of some hits from natural origins as main protease (Mpro) inhibitors.
    Ghosh K; Amin SA; Gayen S; Jha T
    J Mol Struct; 2021 Jan; 1224():129026. PubMed ID: 32834115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical-informatics approach to COVID-19 drug discovery: Monte Carlo based QSAR, virtual screening and molecular docking study of some
    Amin SA; Ghosh K; Gayen S; Jha T
    J Biomol Struct Dyn; 2021 Aug; 39(13):4764-4773. PubMed ID: 32568618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target.
    Kundu D; Selvaraj C; Singh SK; Dubey VK
    J Biomol Struct Dyn; 2021 Jun; 39(9):3428-3434. PubMed ID: 32362243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of Iminosugars as Antiviral Agents against SARS-CoV-2 Main Protease: Inhibitor Design and Optimization, Molecular Docking, and Molecular Dynamics Studies to Explore Potential Inhibitory Effect of 1-Deoxynojirmycin Series.
    Miglani V; Sharma P; Kumar Narula A
    Curr Comput Aided Drug Des; 2023 Aug; ():. PubMed ID: 37612857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors.
    Uniyal A; Mahapatra MK; Tiwari V; Sandhir R; Kumar R
    J Biomol Struct Dyn; 2022 May; 40(8):3609-3625. PubMed ID: 33226303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a "Cocktail" of Potential SARS-COV-2 Main Protease Inhibitors through Virtual Screening of Known Chemical Components of Vitex negundo L. ("Lagundi").
    Cayona R; Creencia E
    Med Chem; 2022; 18(3):364-381. PubMed ID: 34148541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First structure-activity relationship analysis of SARS-CoV-2 virus main protease (Mpro) inhibitors: an endeavor on COVID-19 drug discovery.
    Amin SA; Banerjee S; Singh S; Qureshi IA; Gayen S; Jha T
    Mol Divers; 2021 Aug; 25(3):1827-1838. PubMed ID: 33400085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biflavonoids from
    Lokhande K; Nawani N; K Venkateswara S; Pawar S
    J Biomol Struct Dyn; 2022 Jul; 40(10):4376-4388. PubMed ID: 33300454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation.
    Gogoi B; Chowdhury P; Goswami N; Gogoi N; Naiya T; Chetia P; Mahanta S; Chetia D; Tanti B; Borah P; Handique PJ
    Mol Divers; 2021 Aug; 25(3):1963-1977. PubMed ID: 33856591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions.
    Shawky AM; Almalki FA; Alzahrani HA; Abdalla AN; Youssif BGM; Ibrahim NA; Gamal M; El-Sherief HAM; Abdel-Fattah MM; Hefny AA; Abdelazeem AH; Gouda AM
    Eur J Med Chem; 2024 Nov; 277():116704. PubMed ID: 39121741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploration of Novel Lichen Compounds as Inhibitors of SARS-CoV-2 Mpro: Ligand-Based Design, Molecular Dynamics, and ADMET Analyses.
    Gupta A; Sahu N; Singh AP; Singh VK; Singh SC; Upadhye VJ; Mathew AT; Kumar R; Sinha RP
    Appl Biochem Biotechnol; 2022 Dec; 194(12):6386-6406. PubMed ID: 35921031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of SARS-CoV-2 Main Protease Inhibitors Using Chemical Similarity Analysis Combined with Machine Learning.
    Juárez-Mercado KE; Gómez-Hernández MA; Salinas-Trujano J; Córdova-Bahena L; Espitia C; Pérez-Tapia SM; Medina-Franco JL; Velasco-Velázquez MA
    Pharmaceuticals (Basel); 2024 Feb; 17(2):. PubMed ID: 38399455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragment-based design of SARS-CoV-2 Mpro inhibitors.
    Teli DM; Patel B; Chhabria MT
    Struct Chem; 2022; 33(6):2155-2168. PubMed ID: 36035593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting SARS-CoV-2 Main Protease (MPro) with Kinase Inhibitors: A Promising Approach for Discovering Antiviral and Anti-inflammatory Molecules against SARS-CoV-2.
    Anton DB; Galvez Bulhões Pedreira J; Zvirtes ML; Laufer SA; Ducati RG; Goettert M; Saraiva Macedo Timmers LF
    J Chem Inf Model; 2023 Jul; 63(13):4138-4146. PubMed ID: 37329322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning.
    Santana MVS; Silva-Jr FP
    BMC Chem; 2021 Feb; 15(1):8. PubMed ID: 33531083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mpropred: A machine learning (ML) driven Web-App for bioactivity prediction of SARS-CoV-2 main protease (Mpro) antagonists.
    Ferdous N; Reza MN; Hossain MU; Mahmud S; Napis S; Chowdhury K; Mohiuddin AKM
    PLoS One; 2023; 18(6):e0287179. PubMed ID: 37352252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a simple and miniaturized sandwich-like fluorescence polarization assay for rapid screening of SARS-CoV-2 main protease inhibitors.
    Yan G; Li D; Lin Y; Fu Z; Qi H; Liu X; Zhang J; Si S; Chen Y
    Cell Biosci; 2021 Dec; 11(1):199. PubMed ID: 34865653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico discovery of novel inhibitors from Northern African natural products database against main protease (Mpro) of SARS-CoV-2.
    Byadi S; Oblak D; Kassmi Y; Sadik K; Hachim ME; Podlipnik Č; Aboulmouhajir A
    J Biomol Struct Dyn; 2023 Apr; 41(7):2900-2910. PubMed ID: 35168469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors - an
    Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
    J Biomol Struct Dyn; 2021 Aug; 39(12):4362-4374. PubMed ID: 32568613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Garbage in, garbage out: how reliable training data improved a virtual screening approach against SARS-CoV-2 MPro.
    Ruatta SM; Prada Gori DN; Fló Díaz M; Lorenzelli F; Perelmuter K; Alberca LN; Bellera CL; Medeiros A; López GV; Ingold M; Porcal W; Dibello E; Ihnatenko I; Kunick C; Incerti M; Luzardo M; Colobbio M; Ramos JC; Manta E; Minini L; Lavaggi ML; Hernández P; Šarlauskas J; Huerta García CS; Castillo R; Hernández-Campos A; Ribaudo G; Zagotto G; Carlucci R; Medrán NS; Labadie GR; Martinez-Amezaga M; Delpiccolo CML; Mata EG; Scarone L; Posada L; Serra G; Calogeropoulou T; Prousis K; Detsi A; Cabrera M; Alvarez G; Aicardo A; Araújo V; Chavarría C; Mašič LP; Gantner ME; Llanos MA; Rodríguez S; Gavernet L; Park S; Heo J; Lee H; Paul Park KH; Bollati-Fogolín M; Pritsch O; Shum D; Talevi A; Comini MA
    Front Pharmacol; 2023; 14():1193282. PubMed ID: 37426813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.